Blueprint Medicines Corporation - Common Stock (BPMC)
80.63
-6.48 (-7.44%)
NASDAQ · Last Trade: Apr 5th, 6:07 PM EDT
Via Benzinga · March 20, 2025
Via Benzinga · March 17, 2025

Via Benzinga · March 3, 2025

Via Benzinga · February 13, 2025

Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.
Via Benzinga · January 19, 2025

Why the high growth investor may take a look at BLUEPRINT MEDICINES CORP (NASDAQ:BPMC).
Via Chartmill · December 3, 2024

Via Benzinga · January 13, 2025

JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities.
Via Benzinga · November 14, 2024

Via Benzinga · June 7, 2024

BPMC stock results show that Blueprint Medicines beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024

Via Benzinga · May 2, 2024

Via Benzinga · April 26, 2024